Gritstone bio, Inc. Common Stock
GRTS
GRTS was delisted on the 21st of October, 2024.
102 hedge funds and large institutions have $318M invested in Gritstone bio, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 39 increasing their positions, 30 reducing their positions, and 17 closing their positions.
36% more call options, than puts
Call options by funds: $793K | Put options by funds: $584K
30% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 30
18% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 17
3% more funds holding
Funds holding: 99 → 102 (+3)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1% less capital invested
Capital invested by funds: $321M → $318M (-$2.76M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$7.35M |
| 2 |
D.E. Shaw & Co
New York
|
+$6.61M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$4.84M |
| 4 |
BlackRock
New York
|
+$4.24M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
+$2.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$12.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$3.85M |
| 3 |
Millennium Management
New York
|
-$3.5M |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$2.63M |
| 5 |
JP Morgan Chase
New York
|
-$2.46M |
GRTS Hedge Fund Activity: Q2 2021 in Review
102 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q2 2021, worth a combined $318M — down 0.86% from $321M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new GRTS positions and 17 closed out — a net gain of 3 holders — while 39 added to existing stakes and 30 trimmed.
The largest buyer was Deutsche Bank, adding an estimated $7.35M. The largest seller was Morgan Stanley, cutting an estimated $12.4M.
- 102 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q2 2021, up from 99 in Q1 2021.
- Funds reported $318M of Gritstone bio, Inc. Common Stock stock for Q2 2021, down 0.86% quarter-over-quarter.
- 20 funds opened new Gritstone bio, Inc. Common Stock positions in Q2 2021 and 17 closed out, a net change of +3 holders.
- The largest Gritstone bio, Inc. Common Stock buyer in Q2 2021 was Deutsche Bank, an estimated $7.35M added.
- The largest Gritstone bio, Inc. Common Stock seller in Q2 2021 was Morgan Stanley, an estimated $12.4M sold.
Based on aggregated 13F filings for Q2 2021.